ERBB2 and breast carcinoma: We previously found that human epidermal growth factor receptor 2 (HER2)-amplified BT474 breast cancer persister cells which are sensitized to ferroptosis have decreased expression of nuclear factor E2-related factor 2 (NRF2) target genes, reflecting a disabled antioxidant state (3).